Participant guide
The phases of a clinical trial
Research on a medication moves through phases. Each one answers a different question before the next can begin.
Updated
What each phase looks at
- Phase 1 studies involve a small group and focus on safety and dosage.
- Phase 2 studies involve more people and look at how well the approach works and at side effects.
- Phase 3 studies involve larger groups, compare the approach with existing care, and continue to track side effects.
- Phase 4 studies take place after a product is on the market and follow its use over a longer time.
CNS medication studies by phase right now
As of November 17, 2026, 410 CNS medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. By phase: Early Phase 1 (23), Phase 1 (51), Phase 1/2 (29), Phase 2 (122), Phase 2/3 (8), Phase 3 (103), Phase 4 (69), No phase (5). Studies of devices and behavioral approaches have no phase.
What the phase means for you
The phase tells you how much is already known. Earlier phases involve more unknowns. The consent document states the phase and explains what has been learned so far.
Comparison groups and placebos
Many studies compare groups. One group may receive the investigational approach while another receives existing care or a placebo, which is an inactive look-alike. You are told before you agree whether a placebo may be used and how groups are assigned.
Talk with a study coordinator
Call (888) 927-5768 or send a short form and a coordinator will explain which studies may fit and what the next step looks like. Asking questions does not commit you to anything.
Sources and further reading
- The Drug Development Process — Step 3: Clinical Research — U.S. Food and Drug Administration
- What Are Clinical Trials and Studies? — National Institute on Aging (NIH)
- Glossary of Common Site Terms — ClinicalTrials.gov (National Library of Medicine)